AORTIC CANNULAE AORTIC OPTIFLOW CANNULAE APEX HP AVANT B-CARE5 BMR 1900 BRAT 2 DISPOSABLE BRAT 2 EQUIPMENT C5 CARD 43 CARD EVO CARDIOPLEGIA AORTIC ROOT CANNULAE CARDIOPLEGIA CORONARY OSTIUM 3D CANNULAE CARDIOPLEGIA CORONARY OSTIUM CANNULAE CARDIOPLEGIA RETROGRADE CANNULAE COMPACTFLO EVO CONNECTORS CSC 14 CV CARDIOTOMY CVR 1200 D744 D.A.C. D754 VENOMIDICARD D764 MIDICARD D970 D980 DATA MASTER ECCO ECCO 5 ELECTA CONCEPT DISPOSABLE ELECTA CONCEPT EQUIPMENT EOS EOS ECMO ERC EVH FEMORAL CANNULAE FEMORAL POLYURETHANE CANNULAE HVR EVO KIDS D100 KIDS D101 KIDS D130 / KIDS D131 LILLIPUT LILLIPUT 2 ECMO MICRO PAEDIATRIC CANNULAE PAEDIATRIC POLYURETHANE CANNULAE PERCUTANEOUS INSERTION KITS PRIMO2X REVOLUTION REVOLUTION 5 S5 S5 - ACCESSORIES SC SC - ACCESSORIES SENTRY SIII SIII - ACCESSORIES SORIN AF SORIN GROUP HEMOCONCENTRATORS SUCKERS SYNERGY SYNTHESIS SYNTHESIS R TUBINGS VANGUARD VENOUS CANNULAE VENOUS OPTIFLOW CANNULAE VENTS  Site Map

HOME SOLUTIONS PRODUCTS NEWS AND EVENTS EDUCATIONAL ABOUT US FIELD SERVICE MEMBERS

NEWS 08/06/2010 SORIN GROUP ACQUIRES GISH BIOMEDICAL 13/04/2010 SORIN GROUP SELLS ANGEL™ WHOLE BLOOD SEPARATION SYSTEM AND ACTIVAT® AUTOLOGOUS THROMBIN PROCESSING KIT TO CYTOMEDIX 18/02/2010 SORIN GROUP ANNOUNCES U.S. FDA CLEARANCE OF NEWEST GENERATION HEART LUNG-MACHINE 10/02/2010 SORIN GROUP REPORTS PRELIMINARY CONSOLIDATED RESULTS FOR 2009. STRONG IMPROVEMENT IN PROFITABILITY. FURTHER SIGNIFICANT REDUCTION IN NET DEBT. 22/01/2010 SORIN GROUP LAUNCHES GLOBAL PARTNERSHIP WITH BAMBINI CARDIOPATICI NEL MONDO, A CHARITY PROVIDING CARDIAC CARE FOR DISADVANTAGED CHILDREN 25/06/2009 SORIN GROUP ANNOUNCES THE DELIVERY OF THE 1000TH S5 HEART-LUNG MACHINE 09/02/2009 SORIN GROUP ACQUIRES ENDOSCOPIC VESSEL HARVESTING BUSINESS FROM DATASCOPE, INC. 12/09/2008 SORIN GROUP ANNOUNCES FIRST SUCCESSFUL USES OF NEW PEDIATRIC OXYGENATOR AND ARTERIAL FILTER AT CHILDREN’S MEDICAL CENTER DALLAS 30/06/2008 SORIN GROUP RECEIVES APPROVAL TO MARKET S5 HEART-LUNG MACHINE IN JAPAN 19/12/2007 Milan, Italy - December 19, 2007 21/09/2007 Milan, Italy - September 21, 2007 SORIN GROUP ACQUIRES GISH BIOMEDICAL Sorin Group, (Reuters Code: SORN.MI), a global company and a leader in the treatment of cardiovascular diseases, announced today that it has acquired Gish Biomedical from Ventizz Capital Partners, a private equity group focused on technology-oriented companies. Download document Over 5.000 hospitals use Sorin Group's products in more than 80 countries

HOME | SOLUTIONS | PRODUCTS | NEWS AND EVENTS | EDUCATIONAL | ABOUT US | FIELD SERVICE | MEMBERS

©2009 Sorin Group Italia, All Rights Reserved. Trademark used herein are owned by or licensed to Sorin Group Italia. - P.IVA: 02109510368